Home » Topics » Regulatory

Regulatory
RSS

FDA approves Triumeq for HIV

Aug. 26, 2014

Apixaban granted FDA approval for DVT and PE

Aug. 22, 2014

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Aug. 21, 2014

FDA approves Genzyme's eliglustat for Type 1 Gaucher disease

Aug. 20, 2014

Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA

Aug. 19, 2014

FDA approves Belsomra for insomnia

Aug. 14, 2014

FDA approves oritavancin for acute bacterial skin and skin structure infections

Aug. 7, 2014

Octapharma's Nuwiq receives E.U. approval for hemophilia A

Aug. 6, 2014

Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy

Aug. 6, 2014

Plegridy approved in the E.U. for multiple sclerosis

July 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...